Karlsruhe, den 22.05.2019
Am 16. und 17. Mai 2019 trafen sich die Kunden der Pharmakon zum diesjährigen Customer Advisory Board, um aktuelle Themen rund um Pharma CRM zu besprechen. Zu den Teilnehmern zählten Vertriebsleiter, Key Account Manager sowie CRM- und IT-Verantwortliche unterschiedlicher Pharmaunternehmen mit eigenem Vertrieb, viele davon mit spezialisiertem Außendienst wie z.B. einem Klinikaußendienst.
Im Zentrum der Veranstaltung stand „C-World 4.0“ (Customers World), das neue CRM der Pharmakon und dessen zukünftige Weiterentwicklung.
Holger Schönecker, Geschäftsführer der Pharmakon, demonstrierte 26 CRM-Innovationen aus den Bereichen, Marketing, Vertrieb, Benutzerfreundlichkeit, Datenschutz wie auch Technologie und Sicherheit. Diese wurden von allen Teilnehmern intensiv diskutiert und bewertet.
Kunden der Pharmakon stellten ihre Erfahrungen mit dem neuen CRM vor und berichten über das Feedback ihrer Anwender zur neuen Version. Die teilnehmenden Unternehmen boten eigene Ideen zur Umsetzung an und präsentierten ihre Verbesserungsvorschläge.
Zum Abschluss wurden die Top-Themen der zwei Tage zusammengefasst, welche baldmöglichst umgesetzt werden sollten, und somit die zukünftige Entwicklung gemeinsam festgelegt.
Karlsruhe, den 22.05.2019
According to a recent study of Fact.MR, the natural cold, cough, and sore throat remedies market is expected to surpass revenues worth US$ 4,800 Mn in 2019. The rising popularity of alternative medicine and therapies, coupled with the widespread adoption of natural medication in healthcare worldwide are key factors that are fueling growth of the natural cold, cough, and sore throat remedies market.
The study opines that natural syrups and drops will continue to hold nearly half share of the market, accounting for revenues worth over US$ 2,200 Mn in 2018. The palatable taste of syrups and the presence of multiple ingredients deemed to boost the overall immunity, while combating cold and cough, are pivotal reasons behind increased traction for natural syrups & drops. For instance, sales of Nin Jiom Pei Pa Koa, a Chinese herbal syrup for treating cough, witnessed a significant surge in sales in the US during the flu season in 2018, not only because it was effective but also because consumers found the syrup’s taste surprisingly pleasant.
Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=2988
According to a recently released Fact.MR study, revenues from dyslipidemia therapeutics market surpassed US$ 36 billion in 2018. Low-density lipoproteins held approximately two-thirds of revenues from dyslipidemia therapeutics worldwide in 2018. As high LDL levels have been associated with increased risks of heart attacks, strokes, and other cardiovascular problems in humans, governments around the world are launching various campaigns to raise awareness about the adverse impact of high LDL levels in the blood.
The growing prevalence of cardiovascular disorders worldwide has prompted individuals to effectively manage their LDL levels. To capitalize on the current trends prevalent in the dyslipidemia therapeutics market, pharmaceutical companies continue to strive towards developing new and improved therapies to lower LDL levels, and effectively manage the percentage of other lipids in the blood. A range of new treatments such as combination therapies, gene editing, and novel target drugs are under development, particularly for dyslipidemia therapeutics.
Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=2928
The US$ 1.78 billion actigraphy sensor and PSG devices market on course to grow at 4.3% in 2019, according to Fact.MR’s latest analysis. According to the study, actigraphy sensor and PSG devices market remains a highly consolidated landscape, with Tier I companies maintaining their hegemony despite the foray of new entrants.
According to the study, as a result of the convergence of healthcare and technology, new medical technology (MedTech) products are gaining ground. Growing consumer awareness about—and inclination towards—technologically advanced actigraphy sensor and PSG devices has attracted both, tech industry leaders and startups, to enter the healthcare industry with more innovative actigraphy sensor and PSG devices.
“Ongoing developments and research in the field of sleep disease diagnostics and management reflect in the huge scope of innovation in actigraphy sensor and PSG devices. New entrants are aiming to capitalize on potential opportunities in the actigraphy sensor and PSG devices market by jumping on the technology bandwagon,” says the Fact.MR report.
Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=2829
Growing emphasis on early detection and prevention is driving the melanoma cancer diagnostics market, with global revenue surpassing US$ 800 million in 2018, according to a new study conducted by Fact.MR. The growth of the market is steady in countries/regions with higher prevalence of melanoma. Spending on advanced and safe melanoma cancer diagnostics is growing in the US, as efforts to diagnose the disease at an early stage gain traction. The American Academy of Dermatology estimates around 9,500 people in the US are diagnosed with skin cancer and more than 1 million people in the US are living with melanoma. With skin cancer as most common form of cancer in the US, an increasing number of people are receiving skin cancer diagnosis every year compared to other type of cancers.
Extensive usage of tanning beds is also leading to the rise in melanoma cancer rates globally. Researchers have also found that UV light from sun and tanning beds not only causes melanoma but increases the risk of benign mole which can progress to melanoma. Europe also shows potential for expansion in melanoma cancer diagnostics owing to the treatment rates, government initiatives supporting diagnosis and treatment, and availability of premium drugs.
Rising incidences of cancer and associated mortalities are driving the need for efficient tissue diagnosis. Moreover, growing inclination toward less-invasive diagnostic procedures for cancer and other malignancies drove growth of histopathology testing equipment.
“The American Cancer Society and National Center for Health Statistics have revealed that cancer cases in Unite States crossed 1,685,000 in 2017 and are likely to increase in the coming years. Likewise, according to WHO (World Health Organization) report, emerging economies such as India are witnessing an increase in cancer mortality rates with India reflecting 79 per 100,000 deaths. This has pushed the demand for efficient diagnosis of the disease, which is expected to translate into an increase in histopathology testing equipment sales crossing US$ 5,500 Mn by end of 2018”. – Lead Analyst, Fact.MR Medical Diagnostics Division
Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=2240
The hormone replacement therapy market is foreseen to expand at a significant pace with sales of hormone replacement therapy products crossing US$ 12,000 Mn by 2019 end. Rising incidences of osteoporosis fractures coupled with growing menopause rates among women have remained instrumental in driving the demand for hormone replacement therapy. Fact.MR envisages that the demand for hormone replacement therapy is projected to expand at a CAGR of 6.0% in terms of value throughout the period of forecast, 2018-2028.
Expanding range of menopausal window (45-55 years) coupled with growing number of postmenopausal patients are few of the key factors influencing the growth of the Hormone Replacement Therapy Market. According to the report, the demand for estrogen hormone replacement therapy is expected to grow on the back of growing menopausal rate worldwide. The sales of estrogen hormone replacement therapy are likely to surpass US$ 18,000 Mn by 2028, higher than those of other hormone replacement therapy products including thyroid and growth hormone related hormone replacement therapy products, says the report.
Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=2224
Global sales of kidney stone management devices are likely to surpass 1 million units by 2028, according to a new Fact.MR study. In terms of revenues, the study projects the Kidney Stone Management Devices Market to surpass US$ 1,500 million.
Rising preferences for minimally-invasive and non-invasive surgical procedures continues to be a massive trend in the kidney stone management devices market. Growing incidence rate of kidney stones, combined with the availability of affordable minimally invasive treatment is likely to sustain demand for kidney stone management devices during the forecast period 2018-2028. The report opines that manufacturers will be hard-pressed to develop innovative devices for large stones, as it has remained a longstanding challenge for healthcare providers.
Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=1827
Demand for dental restorative supplies is likely to be on an upswing as several industry-specific and macroeconomic factors continue to influence the dental space. Technological advancements have not left any domain untouched with manufacturers of dental restorative supplies focusing on new innovations in their product lines, says Fact.MR report. Manufacturers of dental restorative supplies are focusing on developing and using advanced material in a bid to enhance the customer satisfaction quotient, achieving sustenance in the competitive Dental Restorative Supplies Market place. FactMR envisages that the demand for dental restorative supplies is projected to expand at a steady CAGR of 4.1% in terms of value during the period of assessment, 2018-2028. Sales of dental restorative supplies during the said period are likely to surpass US$ 6,000 Mn by end of 2028, says the report.
Antiseptics are fast gaining ground an efficacious wound irrigation solution, with the advent of biocompatible antiseptic drugs having high microbiocidal effect that serve as efficient alternative to infection prevention. However, requirement for reviewing antiseptic wound irrigation solution on an ongoing basis, along with special attention to prevent unwanted effects during healing process, are key adoption arresting factors for this variant.
Utilization of antiseptics as wound irrigation solution has been witnessing a marked preference in recent years, overshadowing wetting agents in terms of sales, according to a recent Fact.MR study. Albeit sales rate of antiseptics are likely to be higher, revenues from wetting agents will remain over 1.5 times of antiseptics during the forecast period, 2018 to 2027. Preeminence of wetting agents in wound irrigation solution market rides the coattails of their efficacy in removing debris and barriers in wound dressings, thereby leading to fast recovery.
Request a Free Sample Report Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=1166